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Abstract
Molecular chaperones triage misfolded proteins via action as substrate selectors for quality control
(QC) machines that fold or degrade clients. Herein, the endoplasmic reticulum (ER) associated
Hsp40 JB12 is reported to participate in partitioning mutant conformers of GnRHR, a G-protein
coupled receptor, between ER-associated degradation (ERAD) and a novel ERQC-autophagy
pathway for membrane proteins. ERQC-autophagy degrades E90K-GnRHR because pools of its
partially folded and detergent soluble degradation intermediates are resistant to ERAD. S168R-
GnRHR is globally misfolded and disposed of via ERAD, but inhibition of p97, the protein
retrotranslocation motor, shunts S168R-GnRHR from ERAD to ERQC autophagy. Partially folded
and grossly misfolded forms of GnRHR associate with JB12 and Hsp70. Elevation of JB12
promotes ERAD of S168R-GnRHR, with E90K-GnRHR being resistant. E90K-GnRHR elicits
association of the Vps34 autophagy initiation complex with JB12. Interaction between
ERassociated Hsp40s and the Vps34 complex permits the selective degradation of ERAD-resistant
membrane proteins via ERQC-autophagy.
Introduction
Biogenesis of membrane proteins initiates in the endoplasmic reticulum (ER) and is a
complex process, as domains on both sides of the ER membrane, and within the membrane
bilayer, must fold and assemble (Buchberger et al., 2010; Houck and Cyr, 2012). Loss of
protein function diseases, including cystic fibrosis and hypogonadotropic hypogonadism,
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arise from missense mutations in membrane proteins that lead to misfolding and premature
degradation. Misfolded polytopic membrane proteins are targeted for ER associated
degradation (ERAD) by E3 ubiquitin ligase complexes that utilize the membrane inserted
Hsp40 DNAJB12 (JB12) and cytosolic Hsp70 for substrate selection (Grove et al., 2011;
Hirsch et al., 2009; Meacham et al., 2001; Younger et al., 2006). A key reaction in ERAD is
the p97 dependent extraction, or retrotranslocation, of ubiquitinated membrane proteins
from the membrane to the cytosol, which permits proteasomal degradation to occur
(Brodsky, 2012).
Misfolded proteins with structural restraints that prevent entrance into the proteolytic
chamber of the proteasome, such as aggregates, are subject to autophagic degradation
(Webb et al., 2003). In some cases, mutant membrane and ER luminal proteins form
aggregates, so they are not optimal ERAD clients, and are partitioned to the lysosome for
degradation via autophagy (Houck and Cyr, 2012). How misfolded transmembrane and ER
luminal proteins are partitioned between pathways for folding and proteasomal or lysosomal
degradation is unclear. Seminal studies on ERQC of mutant α1-antitrypsin (α1AT) show
that aggregation-prone α1AT mutants fail to retrotranslocate from the ER lumen, and
consequentially are degraded by autophagy (Teckman and Perlmutter, 2000). Pools of
mutant membrane proteins such as dysferlin, rhodopsin, and mOR-EG are believed to
aggregate in the ER membrane, so a fraction of these mutant proteins are degraded by
autophagic mechanisms (Fujita et al., 2007; Kaushal, 2006; Lu et al., 2003). Yet, how
ERAD-resistant forms of mutant proteins that accumulate in misfolded states in the ER
membrane, but don’t aggregate, are disposed of is not clear?
Molecular chaperones, such as Hsp70, function in the selection of misfolded proteins for
proteasomal degradation (Meacham et al., 2001), and Hsp70 also functions in selection of
cytosolic aggregates for autophagy (Gamerdinger et al., 2011). Thus, components of the
Hsp70 system could cooperate with ER-associated forms of the Vps34/beclin-1
autophagosome initiation complex (Axe et al., 2008; Koyama-Honda et al., 2013; Yang et
al., 2013) to select misfolded membrane proteins for autophagic degradation. Yet, whether
bulk autophagy or a putative ERQC-autophagy pathway degrades ERAD resistant proteins
is a mystery (Bernales et al., 2007).
To uncover new routes for ERQC of membrane proteins, the biogenesis of wild-type and
mutant forms of the G-protein coupled receptor (GPCR) gonadotropin-releasing hormone
receptor (GnRHR) was evaluated. The proper folding of human GnRHR requires action of
the molecular chaperone calnexin (Ayala Yanez and Conn, 2010) and contacts formed
between its seven transmembrane helices are stabilized by two disulfide bonds (Janovick et
al., 2006; Jardon-Valadez et al., 2008). Folding of rat and mouse GnRHR is very efficient,
but folding of human GnRHR is made inefficient by insertion of amino acid K191, which
hinders assembly steps that involve disulfide bond formation (Janovick et al., 2006). The
folding of human GnRHR therefore involves multiple steps with pools of on- and off-
pathway intermediates being triaged for folding and degradation.
Hypogonadotropic hypogonadism is associated with over 20 mutations that further decrease
the intrinsically low efficiency of nascent GnRHR folding and cause nearly all of the mutant
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forms to be retained in the ER (Conn and Ulloa-Aguirre, 2011). Disease-causing mutations
in GnRHR include E90K and S168R, with E90K causing folding defects that are correctable
with chemical folding correctors (pharmacoperones), and S168R leading to non-correctable
global misfolding (Conn and Ulloa-Aguirre, 2011). Wild-type and mutant forms of GnRHR
are referred to here as WT, E90K and S168R. Models of GPCRs show the location of
residue E90 to be within transmembrane domain (TM) 2, where it forms a salt bridge with
K121 in adjacent TM3 (Jardon-Valadez et al., 2008). E90K folding appears to arrest after it
adopts a near native conformation because it can complete folding and escape the ER upon
post-translational application of a pharmacoperone that interacts with the ligand binding site
(Conn and Ulloa-Aguirre, 2011). Yet, rescued E90K has an abnormal conformation because
its cell surface forms are locked in a constitutively active state (Conn and Ulloa-Aguirre,
2011).
Here, we identify an ERQC-autophagy pathway for selective degradation of detergent
soluble and non-aggregated forms of partially folded E90K. Globally misfolded S168R is
primarily degraded by the proteasome. In contrast, a pool of E90K is resistant to ERAD and
accumulates in a complex with Derlin-1, JB12 and the Hsp70, but is degraded by autophagy.
E90K folds to a protease resistant conformation and disruption of GnRHR folding through
impairment of calnexin function or mutation of cysteines involved in disulfide bond
formation permits its disposal by ERAD. Accumulation of partially folded E90K elicits
association of the Vps34/beclin-1 autophagy initiation machinery with ER-associated
complexes that contain E90K, JB12, and Hsp70. E90K dependent association of Vps34/
beclin-1 with JB12 suggests a mechanism for targeted degradation of ERAD-resistant forms
of misfolded GnRHR via ERQC-autophagy.
Results
GnRHR mutants are differentially sensitive to proteasome and lysosome inhibitors
Mechanisms for triage of misfolded membrane proteins and the relative contributions of
ERAD and autophagy in maintenance of ER homeostasis are unclear. Herein, we identify
differences in the conformation of Wt, E90K and S168R that dictate whether GnRHR
degradation intermediates are selected for proteasomal or lysosomal degradation. In these
studies GnRHR-GFP is employed and it migrates as a doublet on SDS-PAGE (Figure 1B).
C-terminally GFP- tagged membrane proteins commonly migrate as a doublet (Geertsma et
al., 2008) and doublets represent two distinct conformational states of the GFP tag. The
lower band retains fluorescence on an SDS-PAGE gel, but the upper band does not
(Geertsma et al., 2008). Both GnRHR-GFP bands in the doublet are equally sensitive to
modulators of protein homeostasis, so they are discussed as a single entity and quantitation
of this signal represents the sum of both bands.
Study of GnRHR degradation is aided by companion studies with model ERAD substrates
that have different domain structures, which invoke use of different sets QC factors for
disposal (Figure 1A). Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
differs from GnRHR since CFTR has several large cytoplasmic domains, which make CFTR
a substrate for a ERQC complexes that contain JB12 and cytosolic Hsp70 (Grove et al.,
2011; Meacham et al., 2001; Younger et al., 2006). ATZ is a mutant variant of α1AT that
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misfolds and aggregates in the ER lumen, with its soluble and aggregated conformers being
degraded by either ERAD or autophagy, respectively (Teckman and Perlmutter, 2000).
Orai1 is a plasma membrane Ca2+ channel, which has four transmembrane spans and
functions as homohexamer. A103E Orai1 has a poorly defined biogenic defect that leads to
its retention in the ER and causes immunodeficiency (McCarl et al., 2009). The contribution
of the proteasome and lysosome to degradation of ERQC substrates is estimated via
comparing changes in their steady-state levels caused by the proteasome inhibitor
bortezomib (bort) or the lysosome inhibitor chloroquine (CQ) (Figure 1B). CQ increases the
pH of lysosomes and thereby functions in Cos-7 cells like the vacuolar-type H+-ATPase
inhibitor Bafilomycin A1 to inhibit activity of lysosomal proteases (Figures S1A-C). This in
turn drives the accumulation of misfolded proteins in autophagosomes and lysosomes
(Klionsky et al., 2008).
During 5 hr incubations with Bort, levels of WT, E90K, and S168R increase differentially;
S168R levels increase 5.5 fold versus 3.6 and 2.2 fold for WT and E90K respectively
(Figure 1B). Likewise, WT, E90K, and S168R levels exhibit differential sensitivity to CQ;
WT, E90K, and S168R increased 1.4, 2.2, and 1.1 fold respectively. ΔF508 CFTR increases
in the presence of bort, but not CQ. In contrast, ATZ increases in the presence of both bort
and CQ. Surprisingly, A103E Orai1-CFP is insensitive to both drugs. WT, E90K, and
S168R exhibited half-lives in cycloheximide (CHX) chase experiments of 1.6, 1.9, and 1.0
hr, respectively (Figures 1C and S1D). Degradation of WT and S168R over a 2 hr CHX
chase period is inhibited by bort, but not CQ. Whereas E90K degradation during this short-
chase is inhibited by CQ, but not bort. A103E Orai1-CFP, is degraded slowly, such that 82%
of the protein still remains after 2 hr of incubation with CHX.
These data suggest that sub-populations of WT and mutant GnRHR conformers -are
degraded by different PQC pathways, with a large pool of E90K being degraded by
autophagy. WT shows greatest sensitivity to bort, but levels do increase 40% with CQ,
suggesting that non-native conformers of WT are also degraded by autophagy. E90K and
ATZ have similar half-lives and CQ sensitivity, which supports the notion that E90K
degradation involves autophagy. In contrast, S168R and ΔF508 CFTR have half-lives that
are primarily sensitive to bort, suggesting that they are ERAD substrates.
Examination of the sensitivity of E90K and ATZ to bort and CQ show that steady-state
accumulation of these proteins is sensitive to long-term inhibition of the proteasome and
lysosome. Yet, short-term degradation rates of newly synthesized E90K and ATZ are most
sensitive to CQ, suggesting that their autophagic degradation can occur at a rapid rate. In
contrast, A103E Orai1-CFP appears resistant to the degradation pathways that clear E90K
and ATZ. E90K appears to be partially folded, and S168R is globally misfolded (Conn and
Ulloa-Aguirre, 2011), so data presented suggest a conformation specific mechanism for
autophagic degradation of membrane proteins.
E90K is soluble in non-ionic detergents, but accumulates in puncta
Protein aggregates are degraded by autophagy and a portion of E90K is degraded by the
lysosome, so the aggregation state of E90K was evaluated (Figure 2A). As expected, ATZ,
but not ATM (a non-disease causing variant of α1AT), forms aggregates because it
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fractionates to a Triton X-100 insoluble fraction of cell extracts. A small portion of WT
Orai1-CFP accumulates in Triton X-100 insoluble aggregates, with most A103E Orai1-CFP
being detergent insoluble. Surprisingly, even though pools of E90K appear to be degraded
by autophagy, it is soluble in Triton X-100, and therefore does not form detergent insoluble
aggregates.
Microscopic analysis shows WT and S168R to colocalize with the ER membrane marker
calnexin in a pattern similar to GFP-ΔF508 CFTR (Figures 2B and S2). Interestingly, some
E90K is found in a diffuse pattern that co-localizes with calnexin, and 80% of cells also
contain E90K puncta that are not enriched in calnexin. E90K puncta are similar in size and
distribution to puncta containing ATZ. A103E Orai1-CFP formed puncta that were enriched
with calnexin and much larger than ATZ and E90K puncta, suggesting that A103E Orai1-
CFP aggregates within the ER membrane. Proteasome inhibition caused GFP-ΔF508 CFTR
to localize in perinuclear aggresomes, but bort does not lead GnRHR-GFP to enter
aggresomes or impact E90K puncta. Thus, the cell utilizes specific QC mechanisms for
handing different conformers of GnRHR, CFTR and Oral1. E90K appears to be the substrate
of a novel ERQC system that targets misfolded and non-aggregated transmembrane proteins
to autophagic puncta for lysosomal degradation.
E90K puncta contain autophagy markers
The mechanism for CQ sensitive E90K degradation was explored through definition of the
requirements for E90K puncta formation. If puncta that contain E90K are autophagic then
modulation of discrete steps of autophagy should impact E90K puncta accumulation (Figure
3A). Rapamycin induces autophagy by inhibiting the kinase mTOR, while LiCl-stimulates
autophagy through inhibition inositol-monophosphatase (IMPase) and the resultant
downstream effects on ER-dependent calcium signaling (Cardenas et al., 2010; Sarkar et al.,
2005). LiCl strongly reduced E90K levels (Figures 3B and S3A), but rapamycin caused an
increase (Figure S3A). Reduction of E90K by LiCl was suppressed by CQ, which suggests
that LiCl stimulates autophagy of E90K (Figure S3B). In parallel, experiments with ATZ,
the same differential sensitivity to rapamycin and LiCl was observed. Similar, results were
observed when the effects of the carbamazepine (an IMPase inhibitor) and rapamycin (an
mTOR inhibitor) on ATZ levels were tested (Hidvegi et al., 2010). LiCl at the high dose of
10mM partially reduced WT and S168R, and inhibition of autophagy with CQ prevented
this effect(Figures S3A-B). ΔF508 CFTR and A103E Orai1-CFP levels were unchanged by
LiCl, suggesting that effects seen on GnRHR-GFP and ATZ are not due to bulk turnover of
the ER (Figure S3A).
LiCl induces degradation of a broad spectrum of autophagic substrates, so we carried out
titrations with LiCl to determine if WT, E90K, and S168R exhibited differential sensitively
to the drug. Indeed, 1mM LiCl selectively reduced WT, E90K, and S168R levels to 93, 53,
and 82% of control (Figure 3B). At 5mM LiCl the levels of WT, E90K, and S168R were 66,
23, and 73% of control. A significant portion of E90K is degraded by autophagy, whereas
the conformation of S168R appears to favor degradation by ERAD. Folding of WT appears
to go off-pathway at different stages with most degradation intermediates being destroyed
by the proteasome and a smaller fraction by autophagy.
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Initiation of autophagy requires the type-III phosphatidylinositol 3-phosphate kinase (PI3K)
VPS34, so entry of E90K into puncta should be blocked by the PI3K inhibitor wortmannin
(Klionsky et al., 2008). Indeed, formation of E90K puncta is disrupted by wortmannin and
insensitive to the late stage autophagy inhibitor CQ (Figure 3A and C). Autophagosome
formation is also dependent upon ATG5 (Figure 3A), so ATG5 knockdown should inhibit
entrance of E90K into puncta. ATG5 levels are reduced 3-fold by siRNA, and this reduces
E90K puncta formation and increases E90K co-localization in the ER with calnexin (Figures
3D and S3C). In wortmannin treated cells, and when ATG5 is depleted, most E90K co-
localizes with calnexin, so E90K accumulates in the ER prior to wortmannin sensitive and
ATG5 dependent passage to puncta.
Authentic autophagic puncta contain marker proteins such as LAMP-2 and p62, and E90K
colocalizes with these autophagic markers (Figure 3E). In contrast, E90K puncta do not
contain markers of the secretory pathway, ERAD, or the proteasome (Figures S3D-F).
Additionally, E90K puncta do not colocalize with SEL1L, a marker of the autophagosome-
like ERAD tuning vesicles (TVs) (Bernasconi et al., 2012). E90K puncta formation is
insensitive to Sel1 knockdown (Figures S3G-H), so E90K puncta are autophagic in nature,
but distinct from ERAD TVs. Misfolded E90K and ATZ are both degraded by LiCl
stimulated autophagic mechanisms. However, ATZ that is co-expressed with E90K does not
colocalize in puncta with E90K (Figure 3E). E90K accumulates in autophagic puncta, as
does ATZ, but ATZ aggregates and detergent soluble E90K are independently selected for
autophagy.
ER-Golgi trafficking is not required for autophagy of E90K
ER-associated E90K may enter autophagy as a passenger of ER membranes that serve as a
source of autophagosomal membranes (Axe et al., 2008; Koyama-Honda et al., 2013).
Alternatively, regions of the ER in which misfolded E90K accumulates could be engulfed
by autophagosomes (Bernales et al., 2007). To address this question we employed
transmission electron microscopy (TEM) coupled with GFP immunogold staining to show
that E90K is on the surface of large 0.5-2μm vesicles (Figures 3F and S4A). The size of the
immunogold positive vesicles and the fact that they contain cellular debris fit criteria of
autophagic vesicles (AVs) (Klionsky et al., 2008). Very few gold particles are seen in cells
expressing untagged E90K GnRHR (Figure S4B). As expected, GFP immunogold staining
of Cos-7 cells expressing GFP-LC3 show localization to the cytosol and surface of AVs
(Figure S4C). These data infer the existence of a pathway for movement of E90K
degradation intermediates from the ER membrane into the autophagosomal membrane
system. Therefore, the engulfment of bulk ER by autophagy is not a likely mechanism for
E90K entry into puncta.
There are multiple potential sources of autophagosomal membrane (Mizushima et al., 2011).
Therefore, support for E90K moving with ER membrane into autophagosomes was obtained
by demonstrating that ER localized E90K moves from the ER to puncta (Figure 4A). A 4 hr
treatment with the reversible wortmannin analog LY-294002 resulted in accumulation of a
large ER pool of E90K that colocalizes with calnexin (Figure 4A). Upon LY-294002 wash-
out and CHX addition, the ER localized E90K moved into puncta.
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To further demonstrate that E90K enters puncta from the ER, we utilized two approaches to
inhibit ER-golgi trafficking and assessed their impact on puncta formation and E90K levels:
(1) Brefeldin A (BFA) and (2) overexpression of H79G Sar1, a dominant negative form of a
small GTPase that inhibits ER-Golgi trafficking (Aridor et al., 1995). BFA and H79G Sar1a
caused intracellular accumulation of the secretory protein ATM and blocked ER-Golgi
trafficking of CFTR as it drove accumulation of the ER localized and core glycosylated B-
band at the expense of more heavily glycosylated C-band (Figure 4B-E). Under these
conditions, BFA and H79G Sar1a, had no effect on E90K levels and accumulation in puncta.
Taken together all these data support the claim that E90K enters autophagic puncta from the
ER membrane.
Conformation Dependent Triage of Misfolded GnRHR for Autophagy or ERAD
E90K folding arrests at a late stage (Conn and Ulloa-Aguirre, 2011), so thermodynamically
stable, but misfolded, forms of E90K could be poor substrates for retrotranslocation and
therefore ERAD-resistant. To test this supposition, we modulated or inhibited specific steps
in GnRHR folding and evaluated changes in E90K’s accumulation and sensitivity to CQ or
bort (Figure 5). GnRHR is a glycoprotein and contains two disulfide bonds (Figure 5A-B),
so its proper folding and QC is facilitated by the glycochaperone calnexin and its associated
protein disulfide isomerase ERp57 (Ayala Yanez and Conn, 2010). When the GnRHR
structure is perturbed by the E90K mutation, the disulfides bonds may be inaccessible to
ERp57 and this could make E90K resistant to ERAD. Indeed, overexpression of ERp57 and
calnexin had no effect on E90K levels (Figure S5C).
The glucosidase inhibitor castanospermine (CAS), which blocks calnexin binding to
glycoproteins, and inhibition of disulfide bond formation with the reducing agent DTT both
caused E90K degradation to become sensitive to bort and insensitive to CQ (Figures 5C and
S5D). Likewise, DTT treatment also accelerated the rate of WT degradation (Figure S5E-F).
These same treatments also prevented E90K accumulation in puncta (Figure 5D). CAS has
no negative effect on global autophagy as seen by monitoring LC3-RFP puncta (Figure
S5B). Therefore, inhibition of GnRHR folding favors proteasomal degradation, which
suggests that abnormally folded forms of E90K are degraded by autophagy.
To directly modulate E90K folding, the destabilizing mutation S168R was introduced into
E90K to form the double mutant, E90K-S168R GnRHR-GFP (E90K-S168R). Additionally,
folding of human GnRHR is made inefficient by the insertion of a lysine (K191) in a
position that appears to destabilize the conformation of the disulfide bond containing loops,
which are located near E90. Deletion of K191 from GnRHR partially suppresses folding
defects caused by E90K, but the majority of E90K K191 GnRHR remains misfolded
(Janovick et al., 2006). Changes in GnRHR caused by these second site mutations prevented
detection of E90K-S168R and E90K-ΔK191 in puncta, and their degradation was sensitive
to bort instead of CQ (Figures 5C-D and S5D). Similarly, a form of E90K, (E90K,C14S,
C114S), in which one cysteine required to form each disulfide bond in GnRHR was
mutated, was not detected in puncta, and its degradation was sensitive to bort instead of CQ.
Changes in the conformation of GnRHR caused by the aforementioned manipulations were
confirmed by limited proteolysis (Figure S5A). WT and E90K exhibited similar resistance to
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digestion with trypsin, which is consistent with E90K accumulating in a partially folded
state. CAS and mutations that cause misfolding of GnRHR caused E90K to accumulate in
conformation that is as sensitive to trypsin as globally misfolded S168R. Partially folded
GnRHR conformers, but not globally misfolded forms, are degraded by autophagy.
Inefficient ERAD leads misfolded GnRHR to be degraded by autophagy
E90K may be degraded by autophagy because its partially folded and detergent soluble
forms are ERAD-resistant. Thus, we compared the sensitivity of WT, E90K, or S168R to
overexpression of components of the RMA1/RNF5 E3 complex. The Hsp40 JB12
cooperates with Hsp70 and Derlin-1 to select membrane proteins for RMA1 dependent
ubiquitination (Grove et al., 2011). Activity of these ERQC factors was elevated to levels
that decrease ΔF508 CFTR accumulation around 70% (Figure 6A). WT and E90K are
largely insensitive to JB12, where as S168R is reduced 60% (Figure 6A). When compared to
S168R and ΔF508 CFTR, E90K is also relatively insensitive to RMA1 and Derlin-1.
If E90K is initially recognized by ERQC factors, but resistant to ERAD its degradation
intermediates should accumulate in association with ERAD machinery. Indeed, E90K
coimmunoprecipitates (co-IPs) with JB12 and Derlin-1 (Figure 6B). The retrotranslocation
factor p97 associates Derlin-1 and RMA1/RNF5 (Younger et al., 2006), and upon inhibition
of early-stages of autophagy with wortmannin, E90K colocalizes in a perinuclear location
with p97 (Figure 6C). These data support the concept that E90K associates with components
of RMA1/RNF5 E3 complex that include p97, but a portion of E90K adopts an ERAD-
resistant conformation and therefore is degraded by autophagy.
To test this concept, we asked if inhibition of p97 function in retrotranslocation caused WT
and S168R to accumulate in puncta. This was accomplished via p97 siRNA knockdown and
chemical inhibition of p97 with DBeQ and Eeyarestatin-1 (Eey1)(Chou et al., 2011; Wang et
al., 2008). SiRNA-mediated p97 knockdown (3-fold KD) promotes accumulation of WT in
puncta (Figures 6D and S6A). Treatment of cells with DBeQ and Eey1 for 4 hours also
caused WT and S168R to localize to E90K-like puncta (Figure 6E). Importantly, DBeQ and
Eey1 did not lead GFP-ΔF508 CFTR to re-localize in puncta, so effects on WT and S168R
are not from gross changes in ER morphology (Figure S6C). Inhibition of autophagy with
wortmannin blocks the DBeQ or Eey1 induced accumulation of WT in puncta (Figure S6D).
Additionally, dual inhibition of the proteasome and lysosome with bort and CQ does not
cause WT to partition to puncta (Figure S6E).
The short exposure of cells to Eey1 and DBeQ used to induce GnRHR accumulation in
puncta does not cause an increase in levels of the ER-stress marker BiP (Figures 6F).
Indicating that autophagic partitioning of WT and S168R GnRHR in response to these drugs
is not due to ER stress. In addition to facilitating ER-protein extraction, p97 also has a late
stage role in autophagy (Chou et al., 2011). Thus, examination of the time course for
degradation of WT and S168R in p97 inhibitor-treated cells is difficult. Nevertheless,
inefficiencies in p97-mediated protein extraction can impact protein triage decisions and
lead forms of GnRHR that are normally degraded by ERAD to accumulate in autophagic
puncta.
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Selective autophagy is mediated by ubiquitin binding proteins (Kirkin et al., 2009; Pankiv et
al., 2007), so we explored the role of ubiquitin in autophagic degradation of GnRHR.
Interestingly, Eey1, but not DBeQ, caused WT to accumulate as a ubiquitinated species
(Figure S6F-G). Thus, DBeQ doesn't drive accumulation of ubiquitinated GnRHR, but still
causes WT and S168R to be partitioned to autophagic puncta. This is consistent with the
observation that Eey1 blocks retrotranslocation, via a mechanism that involves inhibition of
p97-associated deubiquitinases (Wang et al., 2008). Additionally, siRNA knockdown of the
ubiquitin-mediated autophagy cargo selectors p62 and NBR1 did not cause E90K to
accumulate in the ER or disrupt puncta formation (Figure S6H). These data are consistent
with the conformation of GnRHR degradation intermediates dictating whether pools of
misfolded forms are destroyed via ERAD or ERQC-autophagy.
E90K drives association the Vps34 autophagy initiation complex with JB12
To understand how the cell senses accumulation of ERAD-resistant membrane proteins we
asked if E90K impacts activity of the beclin-1/Vps34 PI3K-complex (Figure 7). Beclin-1 is
a scaffold protein that directs Vps34 to drive autophagosome formation and associates with
the ER membrane (Matsunaga et al., 2010). Beclin-1 function is regulated by several kinases
and its activity in autophagy is increased by phosphorylation on residues that include S93
and S96 (Kim et al., 2013). We therefore determined if stimulation of ERQC-autophagy by
LiCl or Eey1 is associated with accumulation of beclin-1 that is phosphorylated on S93 and
S96 (p-beclin-1 S93/96)(Figure 7A). Indeed, phosphorylation of S93/S96 on beclin-1
rapidly increased by almost 4 fold in response to LiCl or Eey1. At the same time, no
increase occurred in expression of the ER stress marker BiP or the heat shock marker Hdj1
(Figure 7A). Notably, E90K causes a dose dependent increase in accumulation of p-beclin-1
S93/96 (Figure 7B), and does not induce expression of BiP (Figure S7D). The cells respond
to inhibition of p97 and E90K accumulation by activating beclin-1 to function in autophagy.
P-beclin-1 S93/S96 functions in bulk autophagy (Kim et al., 2013), so we sought to explore
the mechanism for specification of its action in ERQC-autophagy. Hsp70 and Hsp90
function in the formation of complexes that activate autophagy (Joo et al., 2011; Yang et al.,
2013) and Hsp40 proteins play a major role in specification of Hsp70 function. Since JB12
is an Hsp40 that is present in complexes with ERAD-resistant forms of E90K, we
hypothesized that interactions between JB12 and beclin-1 are associated ERQC-autophagy
of E90K. Indeed, Hsp70, beclin-1, and p97 are present in co-immunoprecipitates with JB12,
and association of beclin-1 with JB12 is dramatically increased by the presence of E90K
(Figure 7C). Substrate dependent interaction between JB12 and beclin-1 is dependent upon
the conformation of the misfolded proteins as S168R, ΔF508-CFTR, and A103E Ora1 has
little detectable effect (Figures S7A-B). Wortmannin prevents E90K from increasing the
association of JB12 and beclin-1, so active autophagy is required for substrate dependent
association of JB12 and beclin-1 (Figure S7B). Consistently, the form of beclin-1 that
associated with JB12 in response to E90K is p-beclin-1 S93/96 (Figure 7D). Additionally,
Vps34 also co-immunoprecipitates with JB12, and E90K dramatically increases detection of
Vps34/JB12 complexes (Figure 7E).
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To evaluate the requirement of JB12 in ERQC of E90K, it was depleted via shRNA by over
90% (Figure S7E). Yet, interpretation of results is complicated because JB12 depletion
decreased cell viability by 40% and caused apoptosis as high level of caspase-3 cleavage
was now detected (Figure S7E-F). Under these conditions, accumulation of E90K, ATZ and
Orai1 was dramatically reduced (Figure S7G), and E90K accumulation was relatively
insensitive to CQ. Autophagy and apoptosis are intimately linked (Eisenberg-Lerner et al.,
2009), so induction of apoptosis in response to loss of JB12 is consistent with it playing an
important role in ERQC autophagy. Data presented place the Vps34/beclin-1 complex in
association with E90K and ERQC complexes that help select globally misfolded GnRHR for
ERAD. The Vps34/beclin-1/ E90K/JB12 complex suggests that E90K is selected for ERQC-
autophagy through interaction between autophagy initiation factors and ERAD-complexes.
Discussion
An ERQC-autophagy pathway for membrane proteins is revealed via demonstration that
different GnRHR mutants are selectively targeted for degradation via either ERAD or
autophagy. Partially folded, detergent soluble, and ERAD-resistant forms of E90K are
degraded by autophagy. Globally misfolded GnRHR, which accumulates resultant from the
S168R mutation, inhibition of calnexin, or blockade of disulfide bonds, is degraded by
ERAD. ERQC-autophagy disposes of E90K at rates similar to ERAD of WT and S168R, so
flux through the pathway is rapid. ERQC-autophagy involves E90K dependent association
of Vps34/beclin-1 with ERQC complexes that contain JB12 and Hsp70. We suggest that
substrate driven association of Vps34/beclin-1 with JB12/Hsp70 initiates ERQC-autophagy
at locations where ERAD-resistant membrane proteins accumulate (Figure 7F).
Cytosolic protein aggregates are degraded by autophagy because they can't be unfolded and
threaded through the narrow proteolytic chamber of the proteasome (Webb et al., 2003). ER
luminal ATZ aggregates are degraded by autophagy due to failed unfolding and
retrotranslocation to cytosol (Hidvegi et al., 2010). Remarkably, nascent E90K is not
aggregation prone and is partially folded. The folding defect in E90K occurs at a late stage
and manifests itself after adoption of a protease resistant conformation, which is similar WT
and requires conserved cysteines. Inefficiencies in disulfide bond formation limit human
GnRHR folding efficiency (Janovick et al., 2006), and blockage of disulfide bond formation
promotes proteasomal degradation of E90K. Thus, we propose that aspects of E90K's
partially folded structure limit ERADs ability to retrotranslocate it to the cytosol, and this
invokes the use of ERQC-autophagy. The disulfide bonds in GnRHR are highly conserved,
so a portion of the misfolded GPCRs rhodopsin and mOR-EG may contain covalent bonds
that limit sensitivity to ERAD and cause their degradation by autophagy (Kaushal, 2006; Lu
et al., 2003). A general role for ERQC-autophagy in protein homeostasis will be established
through identification of additional clients. Demonstration that ERQC-autophagy of E90K
occurs in pituitary tissue where symptoms of hypogonadotropic hypogonadism originate
will aid in demonstration of the physiologic significance of ERQC-autophagy.
Several pieces of data suggest that autophagy of E90K initiates soon after its biosynthesis
and that E90K enters the autophagosomal membranes from ER membranes. E90K
accumulates in the ER when reversible PI3K inhibitors inactivate Vps34, and E90K moves
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from the ER to autophagic puncta upon Vps34 reactivation. This is consistent with the
Vps34/beclin-1 complex being associated with ER, and the human ER serving as a source of
autophagic membranes (Axe et al., 2008). In addition, defects in retrotranslatoction of
misfolded proteins from the ER caused by chemical inhibition of p97 leads ER localized
forms of WT and S168R to be shunted away from ERAD into autophagic puncta. Finally,
the entrance of E90K into autophagic puncta does not require ER to Golgi trafficking.
ERQC-autophagy is selective for partially folded E90K, so it is distinct from bulk ER-
autophagy. In bulk ER-phagy, fragments of ER membranes are detected by EM in the
autophagosome lumen (Bernales et al., 2007), but EM data indicates E90K is located within
autophagosomal membranes. Interestingly, levels of ER lumenal chaperones are regulated
by the membrane inserted ERQC factor Seǀ1ǀ via an autophagic-like pathway known as
ERAD tuning (Bernasconi et al., 2012). Seǀ1ǀ could therefore participate in selection of
E90K for autophagy, but Seǀ1ǀ is not required for E90K puncta formation and Sel1 does not
co-localize with E90K puncta. Therefore, there are distinct mechanisms for tuning Seǀ1ǀ
activity and autophagic degradation of E90K.
Inhibition of basal autophagy blocks E90K degradation, and ER-stress markers are not
induced by E90K, so flux through ERQC-autophagy occurs under normal growth
conditions. Thus, initiation E90K degradation by ERQC-autophagy is not necessarily
dependent on ER-stress. E90K degradation intermediates accumulate in ERQC complexes
that contain JB12, Hsp70 and derlin-1. A pool of beclin-1 is detected in complexes with
JB12, and E90K dramatically increases the interactions of beclin-1 and Vps34 with JB12.
Association of beclin-1 with JB12 is sensitive to the conformation of GnRHR, as an increase
is observed with E90K, but not globally misfolded S168R or ΔF508-CFTR, or aggregated
A103E OraI1. JB12 and Hsp70 select globally misfolded membrane proteins for ERAD
(Grove et al., 2011), so association of Vps34/beclin-1 with JB12 may initiate targeted
clearance of ERAD-resistant E90K from the ER via ERQC-autophagy.
Flux through autophagy is regulated by kinases and other factors that promote formation of
distinct proautophagy Vps34/beclin-1 complexes (Itakura et al., 2008). Lithium chloride
promotes the initiation of autophagy by antagonizing the ER localized IP3-receptor (Sarkar
et al., 2005). Antagonism of the IP3-receptor induces autophagy by regulating activity of
factors that modulate Vps34/beclin-1 activity (Cardenas et al., 2010). Consistently, lithium
chloride induces ERQC-autophagy in a manner associated with increased levels of
proautophagic p-beclin-1-S93/S96 (Kim et al., 2013). However, LiCl has effects on global
autophagy and promotes the degradation of cytosolic protein aggregates as well as E90K
(Sarkar et al., 2005). Thus, effects of LiCl on E90K may occur as a result of the general
induction of autophagy that initiates in the ER. Yet, rapamycin does not induce degradation
of E90K, so there must be a specific mechanism for entrance of ERAD-resistant membrane
proteins into autophagic degradation pathways. Since E90K increases the association of
JB12 and Vps34/beclin-1, we suggest that the specificity of ERQC-autophagy occurs at the
substrate level. .E90K dependent association of beclin-1/Vps34 with JB12 requires PI3K
activity, which is consistent with the participation of JB12/Vps34/beclin-1 in initiation of
ERQC-autophagy.
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The interaction of JB12 with the Vps34 complex provides a new link between ERAD and
autophagy pathways that suggests a mechanism for conformation specific selection of
membrane proteins for ERQC-autophagy. However, details on the mechanism for JB12/
Hsp70 action in regulation of Vps34 in ERQC-autophagy requires study. Hsp70 selects
misfolded proteins for degradation and also facilitates the association of beclin-1 with
Vps34 (Yang et al., 2013). Thus, accumulation of E90K in association with JB12 and Hsp70
on the ER surface could trigger the targeted assembly of proautophagy Vps34 complexes for
function in ERQC-autophagy.
Experimental Procedures
Plasmids, antibodies, and reagents
Reagents were obtained from commercial or academic sources as noted in the supplemental
experimental procedures.
Cell culture , transfections, and chemical treatments
Cos-7 cells were obtained from the American Type Culture Collection (ATCC, Manassas,
VA) and maintained in accordance with ATCC recommendations. Plasmid transfections
were performed using the using the Effectene transfection reagent (Qiagen, Alameda, CA)
and siRNA transfections were performed with Lipofectamine 2000 (Invitrogen, Carlsbad,
CA). For experiments where siRNA and plasmid DNA were both transfected, siRNA
transfection was performed prior to reseeding and subsequent plasmid transfection.
Chemical treatments were performed on cells post-transfection. See supplemental
experimental procedures for more details.
Cycloheximide chases
Transfected Cos-7 cells were incubated with 5μg/ml cycloheximide (CHX; Sigma-Aldrich,
St. Louis, MO) in the presence and absence of 15μM CQ (Sigma-Aldrich, St. Louis, MO) or
10μM bortezomib (LC Laboratories, Woburn, MA). Where indicated, 2mM DTT (Thermo
Fisher, Waltham, MA) or 5mM castanospermine (Sigma-Aldrich, St. Louis, MO) were
added 4 hours prior to CHX addition. Cells were harvested at indicated time points. See
supplemental experimental procedures for more details.
Immunoprecipitation (IP)
Transfected Cos-7 cells were lysed in 200μl of RIPA buffer + N-ethyl-malemide or 50mM
Tris-Cl, 150mM NaCl, 1% Triton X-100, pH 7.6 (TBSt) prior to immunoprecipitation
analysis. See supplemental experimental procedures for more details.
Triton X-100 solubility assay
Harvested cell pellets were lysed in TBSt(1%) and separated into soluble and insoluble
fractions by centrifugation at 20,000xg for 15minutes at 4°C. See supplemental
experimental procedures for more details.
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Cell lysis and western blotting
For all non-immunoprecipitation or TX-100 solubility experiments, harvested cell pellets
were lysed in 200μl of 50mM Tris-Cl pH 7.7, 150mM NaCl, 0.8% SDS, 10mM EDTA with
1× Complete Protease Inhibitor cocktail (Roche, Basel, Switzerland). Lysate was then
subjected to two 30-second sonication prior to Western blotting and data analysis. See
supplemental experimental procedures for more details.
Fluorescence Microscopy
Cos-7 cells were grown on sterile coverslips and fixed prior to immunostaining. In all
images nuclei are stained with DAPI and shown in blue channel. In each experiment 100
cells were scored for a punctate staining pattern. A punctate cell was defined as a cell that
contained more than 10 discrete puncta, of any size, in the indicated channel. See
supplemental experimental procedures for more details.
Immunogold Electron Microscopy
Transfected Cos-7 cells were fixed with 2% paraformaldehyde/0.5% glutaraldehyde prior to
immunostaining and sectioning. Sections were observed using a LEO EM-910 transmission
electron microscope (LEO Electron Microscopy, Thornwood, NY). See supplemental
experimental procedures for more details.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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- A route for ERQC autophagy of soluble ERAD-resistant GnRHR mutants is
discovered.
- Partitioning of E90K GnRHR between ERAD and ERQC autophagy is
conformation dependent.
- ERQC autophagy initiates via E90K GnRHR driven association of Vps34 with
DNAJB12.
- Rates of GnRHR degradation via ERAD or ERQC autophagy are similar.
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Figure 1. Transmembrane and secretory proteins exhibit differential sensitivity to proteasome
and lysosome inhibitors
(A) Topology of nascent disease-associated proteins. (B) Western blot analysis shows
sensitivity of disease protein accumulation to inhibitors of the proteasome (bort; 10μM) or
lysosomal proteases (CQ; 15μM). Transiently transfected Cos-7 cells were treated for 5
hours. (C) CHX chase analysis shows the impact of bort and CQ on the kinetics of disease
protein degradation; 10μg/ml CHX, bort., or CQ were added at t=0. Relative amounts of
respective disease proteins remaining at indicated time points was quantified and the
average quantity −/+ standard error of mean (SEM) for the different disease protein
remaining after 2 hours is depicted in bar graphs. Asterisks (*) indicate a p<0.05 as
determined by the students t-test; n=3. Half-life curves are shown in Figure S1D. See also
Figure S1.
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Figure 2. Analysis of the E90K aggregation state
(A) Analysis of disease protein solubility in the non-ionic detergent Triton X-100. Cos-7 cell
extracts were prepared in lysis buffer supplemented with 1% Triton X-100 and spun at 4°C
at 20,000xg for 15 min: total (T), pellet (P), and supernatant (S). Mature glycosylated Orai1-
CFP is indicated (#). Proteins were detected by western blot and the ratio of pellet to total
was quantified for 3 experiments and graphed +/− SEM. Asterisks (*) indicate p<0.05 via a
students t-test. (B) Fluorescence analysis of disease proteins localization in fixed Cos-7
cells. GFP fusion proteins were detected in the green channel. ATZ (green) was detected by
immunofluorescence, and so was the ER marker calnexin (red). One hundred cells per slide
were scored for the presence of puncta and cells that contained >10 puncta were judged as
punctate. Asterisks (*) indicate a p<0.05 in a t-test, N=3. Green and red channels are shown
unmerged in Figure S2.
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Figure 3. E90K puncta colocalize with autophagic markers and localization is sensitive to
chemical and genetic inhibitors of autophagy.
(A) Model pathway for autophagosome formation. Sites of action for CQ, Wortmannin
(wort), rapamycin (Rap), and lithium chloride (LiCl) are shown. (B) Impact of LiCl on
steady-levels of indicated disease proteins as determined by western blot. Cells were treated
with for 18 hr prior to lysis of Cos-7 cells. C-E show fluorescence micrographs of Cos-7
cells treated as indicated. (C) The impact of Wort and CQ on the accumulation of E90K in
puncta. (D) The impact of siRNA KD of ATG5 on the accumulation of E90K in puncta. One
hundred cells per slide were scored for the presence of puncta and cells that contained >10
puncta were judged as punctate. Data are represented as mean +/−SEM. Asterisks (*)
indicates a p<0.05 in a t-test ; n=3. (E) Localization of E90K in relation to autophagic
markers. Cells immunostained for LAMP-2 (lysosome marker), or p62 (autophagy marker)
are shown. Additionally, cells co-expressing E90K and ATZ were immunostained with
α1AT. Insets show colocalization of LAMP-2 and p62 with E90K puncta. (F) Immunogold
transmission electron microscopy (TEM) of Cos-7 cells expressing E90K GnRHR-GFP.
Immunogold staining was performed against the GFP tag and gold particles are indicated
with arrows. Mitochondria (M), endoplasmic reticulum (ER), nuclei (N), and autophagic
vesicles (AV) are labeled. Scale bar = 1 μM. See also Figures S2 and S3.
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Figure 4. E90K puncta formation and protein levels are not affected by ER-golgi trafficking
inhibition
(A) Effects of LY-294002 treatment and washout on E90K localization in Cos-7 cells. After
4 hours of treatment with LY-294002, media was removed and replaced with media
containing 10μg/ml CHX and 15μM CQ. (B) Effects of the ER-golgi transport inhibitor
Brefeldin-A (BFA) on levels of E90K, WT CFTR, or α1AT M-variant (ATM). (C) Effects
of overexpression of a dominate negative mutant (H79G) of Sar1a on levels of E90K, WT
CFTR, or α1AT M-variant (ATM). Panels B and C show western blots of Cos-7 cells
transiently transfected on E90K GnRHR-GFP, WT CFTR, or α1AT M-variant (ATM).
CFTR blots show core-glycosylated (B-band) and mature-glycosylated (C-band). (D)
Effects of the ER-golgi transport inhibitor Brefeldin-A (BFA) on localization of E90K and
GFP-CFTR. (E) Effects of overexpression of a dominate negative mutant (H79G) of Sar1a
on localization of E90K and GFP-CFTR. Fluorescence micrographs of Cos-7 cells
transiently transfected with substrates are shown in A, D and E. Cell surface localization of
CFTR is shown with arrows. Pearson's correlation coefficients (r) between calnexin (Red)
and GFP (Green) signal are shown. DAPI staining is shown in blue. Data are represented as
mean +/−SEM.
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Figure 5. Interference with GnRHR folding impacts triage of E90K
(A) Ribbon diagram of a GnRHR homology model (Jardon-Valadez et al., 2008). (B) Space
filling model of the GnRHR structure. (C-D) Effects of 5mM castanospermine (CAS), 2mM
DTT (4 hour pre-treatment), and second-site mutations in GnRHR on the half-life and
localization of E90K. Cos-7 cells were treated with 10μg/ml CHX, 10μM bort., or 15μM CQ
at t=0. Bar graphs show the relative amounts of protein remaining at 2 hours. Asterisks (*)
indicate a p<0.05 in a t-test. Half-life curves are shown in Figure S5D. E90K localization
was determined by fluorescence microscopy of cells treated as described. 100 cells/slide
were scored for the presence of puncta. Asterisks (*) indicates p<0.05 in a t-test; N=3. See
also Figure S5. Data are represented as mean +/−SEM.
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Figure 6. Interference with ERAD causes misfolded GnRHR to be partitioned to autophagy
(A) The effect of ER quality control factors overexpression on steady-state levels of WT,
E90K, and S168R GnRHR-GFP in Cos-7 cells. (B) Co-immunoprecipitation of endogenous
derlin-1 and JB12 with WT and E90K GnRHR-GFP from Cos-7 cell lysates. IgG light
chains (LC) are indicated. (C)Colocalization of E90K with immunostained p97 in wort-
treated cells. (D) Inactivation of p97 by siRNA KD leads to detection of WT GnRHR-GFP
in puncta. (E) The impact of the p97 inhibitors DBeQ and Eeyarestatin 1(Eey1) on
accumulation GnRHR-GFP in puncta. (F) Changes in BiP levels in Cos-7 cell treated for 4
hours with indicated chemicals. Western blots were probed for the ER stress marker BiP and
tubulin. Average band density and SEM, N=3, is shown in the bar graph. In panels C-F, cells
were immunostained for Calnexin, JB12, or p97 (Red) and nuclei were stained with DAPI
(Blue). 100 cells/slide were scored for the presence of puncta and quantification shown the
average +/− SEM for N=3. Asterisks (*) indicate a p<0.05 in a t-test. See also Figure S6.
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Figure 7. E90K promotes association of the ERAD factor JB12 with the beclin-1/Vps34
autophagy initiation complex
(A) Phosphorylation of beclin-1-HA on S93/96 in response to treatment with 10mM LiCl
and 15μM Eey1. (B) Phosphorylation of beclin-1-HA on S93/96 in response to E90K
expression. (C) Native IP of JB12-FLAG in the presence and absence of beclin-1-HA and
E90K. (D) Native IP of JB12-FLAG in the presence and absence of beclin-1-HA and E90K
to look at interactions of JB12 with phosphorylated beclin-1. (E) Native IP of JB12-FLAG
in the presence and absence of beclin-1-HA, ATZ, or E90K. (F) Native IP of JB12-FLAG in
the presence of E90K and Vps34-myc. Western blots of samples from Cos-7 cells are
depicted in all panels, see the supplemental experimental procedures for details. See also
Figure S7.
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